Inogen Prices IPO At $16, Low End Of Expected Range

(RTTNews) - Inogen, a medical technology company that develops manufactures portable oxygen concentrators, announced that it has priced initial public offering of 4.41 million common shares at $16.00 per share, which is the low end of the previously expected range of $16.00 and $18.00 per share..

Inogen is offering 3,529,411 shares of common stock and certain selling stockholders are offering 882,352 shares of common stock.

In addition, certain selling stockholders have granted the underwriters a 30-day option to purchase up to 661,764 additional shares of common stock at the initial public offering price.

The company expects to begin trading on The NASDAQ Global Select Market on February 14, 2014, under the symbol "INGN".

J.P. Morgan is acting as sole book-running manager for the offering, Leerink Partners is acting as lead manager, and William Blair and Stifel are acting as co-managers.